Wednesday, May 14, 2025 5/14/2025

Rad-pathomic deep learning models to assist radiologists in differentiating aggressive from indolent prostate cancer on MRI

Award Number: R37CA260346
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Description

Rad-pathomic deep learning models to assist radiologists in differentiating aggressive from indolent prostate cancer on MRI - PROJECT SUMMARY/ABSTRACT Prostate cancer is the second deadliest cancer for American men. MRI is increasingly used to guide prostate biopsies and has potential to spare 500,000 men/year from the side effects of invasive biopsies. Yet, subtle differences in MRI appearance of aggressive vs. indolent (non-lethal) cancer vs. benign tissue creates three problems: missed cancers, high rates of false positives, and only moderate inter-reader agreement among ra- diologists. Selective identification of aggressive and indolent cancers is imperative for reducing cancer death while minimizing side effects from unneeded biopsies. We propose to develop and use pathology-based (pathomic) MRI biomarkers in rad-pathomic deep learning methods to assist radiologists in detecting and localizing aggressive vs. indolent cancers on prostate MRI. In addition, our proposed method will be the first to localize aggressive and indolent cancers when they coexist (76% of index lesions). We performed four preliminary studies in our unique dataset of matched radiology and pathology images. First, we found a high agreement in labeling aggressive vs. indolent cancers between the automated method and two pathologists. Second, we developed pathomic MRI bi- omarkers from MRI features that correlate with features derived from pathology images. Third, we used the biomarkers in rad-pathomic deep learning models to detect cancer (AUC: 0.86) and aggressive cancer (AUC: 0.85) on MRI. Fourth, we showed that combining radiologists and the rad-pathomic deep learning models helped identify 14% more aggressive cancers missed by radiologists. Three innovations will improve the localization of aggressive vs. indolent cancers on prostate MRI. First, we will develop 3D RAPSODI, a novel 3D registration method for 3D reconstructed MRI and pathology images to eliminate the need for slice-to-slice correspondences and map cancer labels from pathology onto MRI. Second, we will leverage our correlation learning method to identify pathomic MRI biomarkers. Third, we will use deep learning models to assist radiologists in localizing aggressive cancer on MRI. Our multidisciplinary team is uniquely positioned to test whether: (Aim 1) pathomic MRI biomarkers empha- size the visual differences of aggressive vs. indolent cancers on MRI; (Aim 2) rad-pathomic deep learn- ing models can reliably and automatically distinguish aggressive from indolent prostate cancers on MRI, and (Aim 3) radiologists assisted by deep learning models have increased detection accuracy and inter-reader agreement than unassisted radiologists. Impact: Our proposed rad-pathomic deep learning models have the potential to improve prostate cancer care in three ways: 1) detecting and targeting aggressive cancers that are currently missed in ~50,000 men/year; 2) eliminating up to 500,000 unnecessary biopsies/year in men with no cancer or indolent cancers; and 3) reduc- ing the number of biopsy samples needed to detect aggressive cancers (1-2 vs. 12-18 currently).


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $539,620 )
2025	2025	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Detection and Diagnosis Research	000	4	12/31/2024	NON-COMPETING CONTINUATION	$539,620
														Subtotal = $539,620

Issue Date FY: 2024 ( Subtotal = $593,503 )
2024	2024	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Detection and Diagnosis Research	001	3	4/17/2024	NON-COMPETING CONTINUATION	$31,237
2024	2024	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Detection and Diagnosis Research	000	3	1/4/2024	NON-COMPETING CONTINUATION	$562,266
														Subtotal = $593,503

Issue Date FY: 2023 ( Subtotal = $536,074 )
2023	2023	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Detection and Diagnosis Research	001	2	3/20/2023	NON-COMPETING CONTINUATION	$43,760
2023	2023	LELAND STANFORD JUNIOR UNIVERSITY, THE	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Detection and Diagnosis Research	000	2	12/23/2022	NON-COMPETING CONTINUATION	$492,314
														Subtotal = $536,074

Issue Date FY: 2022 ( Subtotal = $573,475 )
2022	2022	LELAND STANFORD JUNIOR UNIVERSITY, THE	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Detection and Diagnosis Research	000	1	1/12/2022	NEW	$573,475
														Subtotal = $573,475

Grand Total All Awards = $2,242,672

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Rad-pathomic deep learning models to assist radiologists in differentiating aggressive from indolent prostate cancer on MRI

Award Number: R37CA260346

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer